Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mujoo

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Biochemical Journal|October 15, 1983
Isolation, characterization and synthesis of alpha-foetoprotein from neonatal-rat skinK Mujoo, M Ali, M K Sahib
Journal of Neurochemistry|November 1, 1983
Isolation, characterization, and synthesis of alpha-fetoprotein from neonatal rat brainK Mujoo, M Ali, M K Sahib
Brain Research|December 1, 1982
Synthesis and secretion of alpha-fetoprotein and albumin by newborn rat brain cells in cultureM Ali, K Mujoo, M K Sahib
The Biochemical Journal|March 15, 1983
Identification and origin of oestradiol-binding protein in immature rat skin. Demonstration of oestrophilic alpha-foetoprotein synthesis and secretion by developing rat skin explants in cultureM Ali, K Mujoo, M K Sahib
Cancer Research|June 1, 1991
Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinationsK Mujoo, M G Rosenblum, J L Murray
The Journal of Biological Chemistry|August 5, 1986
Characterization of a unique glycoprotein antigen expressed on the surface of human neuroblastoma cellsK Mujoo, R C Spiro, R A Reisfeld
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacementK. Mujoo, L. Zhang, J. Klostergaard, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft modelsM G Rosenblum, L Cheung, K Mujoo, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-geloninK Mujoo, L Cheung, J L Murray, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2K Mujoo, R A Reisfeld, L Cheung, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Biochemical Journal|October 15, 1983
Isolation, characterization and synthesis of alpha-foetoprotein from neonatal-rat skinK Mujoo, M Ali, M K Sahib
Journal of Neurochemistry|November 1, 1983
Isolation, characterization, and synthesis of alpha-fetoprotein from neonatal rat brainK Mujoo, M Ali, M K Sahib
Brain Research|December 1, 1982
Synthesis and secretion of alpha-fetoprotein and albumin by newborn rat brain cells in cultureM Ali, K Mujoo, M K Sahib
The Biochemical Journal|March 15, 1983
Identification and origin of oestradiol-binding protein in immature rat skin. Demonstration of oestrophilic alpha-foetoprotein synthesis and secretion by developing rat skin explants in cultureM Ali, K Mujoo, M K Sahib
Cancer Research|June 1, 1991
Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinationsK Mujoo, M G Rosenblum, J L Murray
The Journal of Biological Chemistry|August 5, 1986
Characterization of a unique glycoprotein antigen expressed on the surface of human neuroblastoma cellsK Mujoo, R C Spiro, R A Reisfeld
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Emergence of cisplatin-resistant cells from the OVCAR-3 ovarian carcinoma cell line with p53 mutations, altered tumorigenicity, and increased apoptotic sensitivity to p53 gene replacementK. Mujoo, L. Zhang, J. Klostergaard, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft modelsM G Rosenblum, L Cheung, K Mujoo, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-geloninK Mujoo, L Cheung, J L Murray, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2K Mujoo, R A Reisfeld, L Cheung, et al.
Pageof 3